H19, for instance, is overexpressed in HCC patients with a high bone metastasis tendency and was found to promote p38MAPK dephosphorylation by facilitating the interaction between protein phosphatase 1 catalytic subunit alpha (PPP1CA) and p38 in preclinical studies [37]. The gene discussed is H19; the disease is hepatocellular carcinoma.